Literature DB >> 12843357

Multiple levels of regulation of the interleukin-6 system in stroke.

Daniela Acalovschi1, Tina Wiest, Marius Hartmann, Maryam Farahmi, Ulrich Mansmann, Gerd U Auffarth, Armin J Grau, Fiona R Green, Caspar Grond-Ginsbach, Markus Schwaninger.   

Abstract

BACKGROUND AND
PURPOSE: Serum levels of the cytokine interleukin-6 (IL-6) rise markedly in stroke. IL-6 is a key regulator of inflammatory mechanisms that play an important part in stroke pathophysiology. The action of IL-6 is modified by its soluble receptor subunits sgp130 and sIL-6R. The purpose of this study was to investigate whether serum levels of the receptor subunits are changed after ischemic stroke and to define the role of genetic influences on IL-6 expression in acute stroke.
METHODS: In 48 patients with acute stroke and 48 age- and sex-matched control subjects, serum concentrations of IL-6, sgp130, and sIL-6R were measured by enzyme-linked immunosorbent assay. Furthermore, IL-6 promoter haplotypes comprising 4 different polymorphisms (-597G-->A, -572G-->C, -373A(n)T(n), -174G-->C) were determined by DNA sequencing and allele-specific oligonucleotide polymerase chain reaction. The effect of the common haplotypes on IL-6 gene transcription was tested by transfecting reporter fusion genes in the astrocytelike cell line U373.
RESULTS: Whereas serum concentrations of IL-6 significantly rose (P<0.001), sgp130 levels were transiently reduced after stroke (P<0.05), and sIL-6R levels remained unchanged. IL-6 levels depended on the infarct size and the haplotype of the promoter region. The common haplotype A-G-8/12-C was associated with low IL-6 levels after stroke and a reduced induction of IL-6 transcription on stimulation with an adenosine analog in vitro.
CONCLUSIONS: The data demonstrate genetic variation in the expression of IL-6 in stroke. Induction of the inflammatory response by IL-6 might be enhanced by a transient downregulation of the potential IL-6 antagonist sgp130.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843357     DOI: 10.1161/01.STR.0000079815.38626.44

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  35 in total

1.  Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage.

Authors:  Asita Sarrafzadeh; Florian Schlenk; Christine Gericke; Peter Vajkoczy
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 2.  Analytic review: Interleukin-6 in surgery, trauma, and critical care: part I: basic science.

Authors:  Randeep S Jawa; Sergio Anillo; Kristin Huntoon; Heinz Baumann; Mahmoud Kulaylat
Journal:  J Intensive Care Med       Date:  2011 Jan-Feb       Impact factor: 3.510

3.  Evidence that meningeal mast cells can worsen stroke pathology in mice.

Authors:  Ahmet Arac; Michele A Grimbaldeston; Andrew R B Nepomuceno; Oluwatobi Olayiwola; Marta P Pereira; Yasuhiro Nishiyama; Anna Tsykin; Gregory J Goodall; Ulrich Schlecht; Hannes Vogel; Mindy Tsai; Stephen J Galli; Tonya M Bliss; Gary K Steinberg
Journal:  Am J Pathol       Date:  2014-09       Impact factor: 4.307

4.  Dynamics of inflammatory markers in post-acute stroke patients undergoing rehabilitation.

Authors:  Bogdan Nicolae Manolescu; Mihai Berteanu; Luminița Dumitru; Horațiu Dinu; Alina Iliescu; Ileana Cornelia Fărcășanu; Eliza Oprea; Suzana Vlădoiu; Oana Popa; Olga Ianăș
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

Review 5.  Interleukin-6 in surgery, trauma, and critical care part II: clinical implications.

Authors:  Randeep S Jawa; Sergio Anillo; Kristin Huntoon; Heinz Baumann; Mahmoud Kulaylat
Journal:  J Intensive Care Med       Date:  2011 Mar-Apr       Impact factor: 3.510

6.  Protective effect of diphenyl diselenide on ischemia and reperfusion-induced cerebral injury: involvement of oxidative stress and pro-inflammatory cytokines.

Authors:  César A Brüning; Marina Prigol; Cristiane Luchese; Cristiano R Jesse; Marta M M F Duarte; Silvane S Roman; Cristina W Nogueira
Journal:  Neurochem Res       Date:  2012-07-31       Impact factor: 3.996

7.  Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients.

Authors:  Tomasz Dziedzic; Elzbieta A Gryz; Wojciech Turaj; Agnieszka Slowik; Andrzej Szczudlik
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  A novel method for subarachnoid hemorrhage to induce vasospasm in mice.

Authors:  Tamer Altay; Saksith Smithason; Nina Volokh; Peter A Rasmussen; Richard M Ransohoff; J Javier Provencio
Journal:  J Neurosci Methods       Date:  2009-07-01       Impact factor: 2.390

Review 9.  Neuroprotective effects of estrogens following ischemic stroke.

Authors:  Shotaro Suzuki; Candice M Brown; Phyllis M Wise
Journal:  Front Neuroendocrinol       Date:  2009-05-03       Impact factor: 8.606

Review 10.  Inflammatory mechanisms in ischemic stroke: therapeutic approaches.

Authors:  Shaheen E Lakhan; Annette Kirchgessner; Magdalena Hofer
Journal:  J Transl Med       Date:  2009-11-17       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.